Acute lung injury is characterized by acute respiratory insufficiency with tachypnea, cyanosis
refractory to oxygen, decreased lung compliance, and diffuse alveolar infiltrates on chest X …

COVID-19 is also manifested with hypercoagulability, pulmonary intravascular coagulation,
microangiopathy, and venous thromboembolism (VTE) or arterial thrombosis. Predisposing …

Background COVID-19-associated acute respiratory distress syndrome (ARDS) is
associated with significant morbidity and high levels of mortality. This paper describes the …

Rationales and uncertainties for aspirin use in COVID-19: a narrative review - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Since its emergence, the COVID-19 pandemic has been ravaging the medical and
economic sectors even with the significant vaccination advances. In severe presentations …

Platelets are central players in thrombosis and hemostasis but are increasingly recognized
as key components of the immune system. They shape ensuing immune responses by …

Selective serotonin reuptake inhibitors (SSRIs) have anti‐inflammatory properties that may
have clinical utility in treating severe pulmonary manifestations of COVID‐19. SSRIs exert …

Introduction: Whether aspirin or other antiplatelet drugs can reduce mortality among patients
with coronavirus disease (COVID-19) remains controversial. Methods: We identified …

Acute respiratory distress syndrome (ARDS) is a common and devastating syndrome that
contributes to serious morbidities and mortality in critically ill patients. No known …

Microvascular immunothrombotic dysregulation is a critical process in the pathogenesis of
severe systemic inflammatory diseases. The mechanisms controlling immunothrombosis in …